This week's round-up of pharma licensing deals features alliances involving Tenaya Therapeutics, Sino Bio, Antengene, and A2A Pharma. Alnylam is broadening its position in the area of RNA interference ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results